Health In Tech, Inc. — Form 8-K
Filed November 18, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 42/100
What the filing says
Health In Tech appointed Christina R. Valauri (effective November 12, 2026) and Tim Cortes (November 18, 2026) as independent directors. Valauri brings 30+ years of Wall Street equity research and capital markets experience, including roles at Cantor Fitzgerald and ING Barings, and currently serves on boards of Valion Bio and Precipio. Cortes brings 30+ years in technology and clean energy innovation. Both join the Audit, Compensation, and Nominating/Governance committees; Cortes chairs the Compensation Committee. No equity grants, compensation amounts, or financial terms are disclosed.
Why this rating
Board enhancement with experienced independent directors addresses governance gaps at ~$12.7M company facing Nasdaq compliance risks and leadership transition. Material for small cap but routine director appointments without financial impact.
See more from November 18, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.